Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Companies  >  All News

News : Companies
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors

Yestar Healthcare : COMPANY'S STATEMENT ON THE INTERIM RESULTS ANNOUNCEMENT OF THE COMPANY FOR THE SIX MONTHS E... 2019-08-15

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/14/2019 | 09:22pm EDT

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Yestar Healthcare Holdings Company Limited

巨 星 醫 療 控 股 有 限 公 司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 2393)

COMPANY'S STATEMENT ON THE

INTERIM RESULTS ANNOUNCEMENT OF THE COMPANY

FOR THE SIX MONTHS ENDED 30 JUNE 2019

Reference is made to the interim results announcement of Yestar Healthcare Holdings Company Limited (the ''Company'') (the ''Company'', together with its subsidiaries, the ''Group'') dated 15 August 2019 for the six months ended 30 June 2019 (the ''2019 Interim Results Announcement''). Unless otherwise defined, terms used therein shall bear the same meanings as defined in the 2019 Interim Results Announcement.

As disclosed in the 2019 Interim Results Announcement, the Company recorded other payables and accruals amounted to RMB1,681 million under current liabilities (the ''Current Liability'') in our interim consolidated statement of financial.

The board of directors (the ''Board'') of the Company would hereby advise shareholders and potential investors that the Current Liability includes the amount granted to non- controlling shareholders to dispose of their remaining interests, which amounted to RMB1,536 million. The Company would acquire such interests in an appropriate time and mode with reference to our financial position.

As such, the recognition of the Current Liability in relation to the related acquisition would have no material impact and restriction on the liquidity of the Company.

As at the date of this statement, no definitive legally binding agreement or contract detailing the terms and conditions of the proposed acquisition for the remaining interests has been entered into by the Company. The proposed acquisition is subject to further negotiation among parties to the agreement, and the Company will publish announcement upon execution of the agreement once all terms have been concluded.

- 1 -

Therefore, the Board believes that the Current Liability has no material impact on liquidity including cash and funding of the Company.

By Order of the Board

Yestar Healthcare Holdings Company Limited

Hartono James

Chairman, CEO and Executive Director

Shanghai, 15 August 2019

As at the date of this announcement, the executive Directors are Mr. Hartono James, Ms. Wang Ying, Mr. Chan To Keung, Ms. Wang Hong and Mr. Chan Chung Man; the independent non-executive Directors are Dr. Hu Yiming, Mr. Karsono Tirtamarta (Kwee Yoe Chiang) and Mr. Sutikno Liky.

- 2 -

Disclaimer

Yestar Healthcare Holdings Co. Ltd. published this content on 15 August 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 August 2019 01:21:01 UTC

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news "Companies"
12:30pConcordia University-Portland to Open Nursing Innovation Center
GL
12:30p2019 State of DevOps Report Released; Research Links Fast, Reliable Software Delivery to Business Transformation
GL
12:28pMUTUALFIRST FINANCIAL, INC. : Declares Cash Dividend
PR
12:28pESKATON : Earns Ranking in National Top 50 "Best Workplaces for Aging Services" by Great Place to Work® and FORTUNE Magazine
PR
12:26pLOGICALIS : Leads Network Transformation for Desert Radiology
PR
12:26pTOTAL :  Disclosure of Transactions in Own Shares
BU
12:25pArch Scientists Publish Data on the Mechanism of Action and Efficacy of Lead Drug Candidate Metablok in the Prevention of Inflammation and Organ Damage
GL
12:23pADYEN N : founders selling 15 percent of their holdings
RE
12:23pCATCO REINSURANCE OPPORTUNITIES FUND : Net Asset Value 31 July 2019
PU
12:23pCADENCE MINERALS : Macarthur Minerals Lake Giles Update
PU
Latest news "Companies"
Advertisement